{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:03:36Z","timestamp":1781049816552,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04923-4","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:46:58Z","timestamp":1777265218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of riluzole on cognitive and functional outcomes after severe traumatic brain injury: a randomized controlled trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Seyed Hamidreza","family":"Shojaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Kavakebian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Derakhshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"4923_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1556147","volume":"13","author":"J Yan","year":"2025","unstructured":"Yan J, Wang C, Sun B. Global, regional, and national burdens of traumatic brain injury from 1990 to 2021. Front Public Health. 2025;13:1556147.","journal-title":"Front Public Health"},{"issue":"4","key":"4923_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.amepre.2025.01.001","volume":"68","author":"H Zhong","year":"2025","unstructured":"Zhong H, Feng Y, Shen J, Rao T, Dai H, Zhong W, et al. Global Burden of Traumatic Brain Injury in 204 Countries and Territories From 1990 to 2021. Am J Prev Med. 2025;68(4):754\u201363.","journal-title":"Am J Prev Med."},{"issue":"11","key":"4923_CR3","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S1474-4422(22)00309-X","volume":"21","author":"AIR Maas","year":"2022","unstructured":"Maas AIR, Menon DK, Manley GT, Abrams M, \u00c5kerlund C, Andelic N, et al. Traumatic brain injury: progress and challenges in prevention, clinical care, and research. The Lancet Neurology. 2022;21(11):1004\u201360.","journal-title":"The Lancet Neurology."},{"issue":"1","key":"4923_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","volume":"80","author":"N Carney","year":"2017","unstructured":"Carney N, Totten AM, O\u2019Reilly C, Ullman JS, Hawryluk GW, Bell MJ, et al. Guidelines for the Management of Severe Traumatic Brain Injury. Fourth Edition Neurosurgery. 2017;80(1):6\u201315.","journal-title":"Fourth Edition. Neurosurgery."},{"key":"4923_CR5","unstructured":"guideline NG232 N. Head Injury: assessment and early management. 2023."},{"issue":"3","key":"4923_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/life15030369","volume":"15","author":"N AlShahwan","year":"2025","unstructured":"AlShahwan N, Aldeligan SH, AlQahtani AS, Sallam MS, Alqusiyer A, Fallatah AA, et al. Traumatic Brain Injury Guideline Implementation at a University Hospital in Saudi Arabia. Life. 2025;15(3):369.","journal-title":"Life."},{"issue":"3","key":"4923_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnrt.2025.100191","volume":"13","author":"Q Zhou","year":"2025","unstructured":"Zhou Q, Shen W, Wen L. Advances in clinical neurorestorative treatments in brain trauma. J Neurorestoratology. 2025;13(3):100191.","journal-title":"J Neurorestoratology"},{"issue":"6","key":"4923_CR8","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1007\/s13311-023-01438-5","volume":"20","author":"R Diaz-Arrastia","year":"2023","unstructured":"Diaz-Arrastia R, Kochanek PM. Pharmacotherapy for traumatic brain injury: the next generation of clinical trials. Neurotherapeutics. 2023;20(6):1428\u201332.","journal-title":"Neurotherapeutics"},{"issue":"2","key":"4923_CR9","first-page":"181","volume":"28","author":"M Hajinejad","year":"2025","unstructured":"Hajinejad M, Gharaeian Morshed A, Narouiepour A, Izadpanahi M, Taheri MM, Sadeghian MH, et al. NMDA receptors antagonists alleviated the acute phase of traumatic brain injury. Iran J Basic Med Sci. 2025;28(2):181\u20136.","journal-title":"Iran J Basic Med Sci."},{"key":"4923_CR10","doi-asserted-by":"crossref","unstructured":"Wu W-l, Gong X-x, Qin Z-h, Wang Y. Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases\u2014an update. Acta Pharmacologica Sinica. 2025.","DOI":"10.1038\/s41401-025-01576-w"},{"issue":"6","key":"4923_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70110","volume":"169","author":"JH Nguyen","year":"2025","unstructured":"Nguyen JH, Zhang X, Eby HM, Alganem K, Ryan WG, Lmami AS, et al. Multi-Omic Analysis of Glutamate Excitotoxicity in Primary Neuronal Cultures. J Neurochem. 2025;169(6):e70110.","journal-title":"J Neurochem."},{"issue":"12","key":"4923_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126521","volume":"25","author":"N Nicosia","year":"2024","unstructured":"Nicosia N, Giovenzana M, Misztak P, Mingardi J, Musazzi L. Glutamate-mediated excitotoxicity in the pathogenesis and treatment of neurodevelopmental and adult mental disorders. Int J Mol Sci. 2024;25(12):6521.","journal-title":"Int J Mol Sci"},{"key":"4923_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1466953","volume":"15","author":"T Kyllo","year":"2024","unstructured":"Kyllo T, Allocco D, Hei LV, Wulff H, Erickson JD. Riluzole attenuates acute neural injury and reactive gliosis, hippocampal-dependent cognitive impairments and spontaneous recurrent generalized seizures in a rat model of temporal lobe epilepsy. Front Pharmacol. 2024;15:1466953.","journal-title":"Front Pharmacol"},{"issue":"17\u201318","key":"4923_CR14","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1089\/neu.2023.0163","volume":"40","author":"MG Fehlings","year":"2023","unstructured":"Fehlings MG, Moghaddamjou A, Harrop JS, Stanford R, Ball J, Aarabi B, et al. Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled. Double-Blinded Trial J Neurotrauma. 2023;40(17\u201318):1878\u201388.","journal-title":"Double-Blinded Trial. J Neurotrauma."},{"key":"4923_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105863","volume":"118","author":"MG Fehlings","year":"2025","unstructured":"Fehlings MG, Pedro KM, Alvi MA, Moghaddamjou A, Harrop JS, Stanford R, et al. The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic technique. EBioMedicine. 2025;118:105863.","journal-title":"EBioMedicine."},{"issue":"4","key":"4923_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"4923_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/00002060-199304000-00005","volume":"72","author":"CV Granger","year":"1993","unstructured":"Granger CV, Hamilton BB, Linacre JM, Heinemann AW, Wright BD. Performance profiles of the functional independence measure. Am J Phys Med Rehabil. 1993;72(2):84\u20139.","journal-title":"Am J Phys Med Rehabil"},{"issue":"8","key":"4923_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1089\/neu.1998.15.573","volume":"15","author":"JT Wilson","year":"1998","unstructured":"Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow outcome scale and the extended Glasgow outcome scale: guidelines for their use. J Neurotrauma. 1998;15(8):573\u201385.","journal-title":"J Neurotrauma"},{"issue":"7872","key":"4923_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","volume":"2","author":"G Teasdale","year":"1974","unstructured":"Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81\u20134.","journal-title":"Lancet"},{"issue":"9","key":"4923_CR20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJM199403033300901","volume":"330","author":"G Bensimon","year":"1994","unstructured":"Bensimon G, Lacomblez L, Meininger V, ALS\/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994;330(9):585\u201391.","journal-title":"N Engl J Med"},{"issue":"3","key":"4923_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/neu.2013.2969","volume":"31","author":"RG Grossman","year":"2014","unstructured":"Grossman RG, Fehlings MG, Frankowski RF, Burau KD, Chow DS, Tator C, et al. A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. J Neurotrauma. 2014;31(3):239\u201355.","journal-title":"J Neurotrauma"},{"issue":"1","key":"4923_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000514673","volume":"11","author":"V Rashedi","year":"2021","unstructured":"Rashedi V, Foroughan M, Chehrehnegar N. Psychometric properties of the Persian Montreal cognitive assessment in mild cognitive impairment and Alzheimer disease. Dement Geriatr Cogn Dis Extra. 2021;11(1):51\u20137.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"26","key":"4923_CR23","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1056\/NEJMoa1404304","volume":"371","author":"DW Wright","year":"2014","unstructured":"Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, et al. Very Early Administration of Progesterone for Acute Traumatic Brain Injury. New England Journal of Medicine. 2014;371(26):2457\u201366.","journal-title":"New England Journal of Medicine."},{"key":"4923_CR24","doi-asserted-by":"crossref","unstructured":"Skolnick BE, Maas AI, Narayan RK, Hoop RGvd, MacAllister T, Ward JD, et al. A Clinical Trial of Progesterone for Severe Traumatic Brain Injury. New England Journal of Medicine. 2014;371(26):2467-76.","DOI":"10.1056\/NEJMoa1411090"},{"issue":"6 Suppl 4","key":"4923_CR25","first-page":"S233","volume":"47","author":"A Doble","year":"1996","unstructured":"Doble A. The pharmacology and mechanism of action of riluzole. Neurology. 1996;47(6 Suppl 4):S233-41.","journal-title":"Neurology"},{"key":"4923_CR26","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.3390\/molecules20057775","volume":"20","author":"N Nagoshi","year":"2015","unstructured":"Nagoshi N, Nakashima H, Fehlings M. Riluzole as a neuroprotective drug for spinal cord injury: from bench to bedside. Molecules. 2015;20:7775\u201389.","journal-title":"Molecules"},{"issue":"5","key":"4923_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cjtee.2015.03.007","volume":"19","author":"H Zhang","year":"2016","unstructured":"Zhang H, Zhang XN, Zhang HL, Huang L, Chi QQ, Zhang X, et al. Differences in cognitive profiles between traumatic brain injury and stroke: A comparison of the Montreal Cognitive Assessment and Mini-Mental State Examination. Chin J Traumatol. 2016;19(5):271\u20134.","journal-title":"Chin J Traumatol."},{"issue":"2","key":"4923_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/09084282.2013.778260","volume":"21","author":"E de Guise","year":"2014","unstructured":"de Guise E, Alturki AY, LeBlanc J, Champoux MC, Couturier C, Lamoureux J, et al. The Montreal Cognitive Assessment in persons with traumatic brain injury. Appl Neuropsychol Adult. 2014;21(2):128\u201335.","journal-title":"Appl Neuropsychol Adult."},{"issue":"10","key":"4923_CR29","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-021-06503-1","volume":"47","author":"JL Stollings","year":"2021","unstructured":"Stollings JL, Kotfis K, Chanques G, Pun BT, Pandharipande PP, Ely EW. Delirium in critical illness: clinical manifestations, outcomes, and management. Intensive Care Med. 2021;47(10):1089\u2013103.","journal-title":"Intensive Care Med"},{"issue":"4","key":"4923_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ccc.2018.06.009","volume":"34","author":"TD Girard","year":"2018","unstructured":"Girard TD. Sedation, delirium, and cognitive function after critical illness. Crit Care Clin. 2018;34(4):585\u201398.","journal-title":"Crit Care Clin"},{"issue":"22","key":"4923_CR31","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1089\/neu.2018.6153","volume":"36","author":"TE Wilkins","year":"2019","unstructured":"Wilkins TE, Beers SR, Borrasso AJ, Brooks J, Mesley M, Puffer R, et al. Favorable Functional Recovery in Severe Traumatic Brain Injury Survivors beyond Six Months. J Neurotrauma. 2019;36(22):3158\u201363.","journal-title":"J Neurotrauma."},{"key":"4923_CR32","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1080\/02699050701727460","volume":"21","author":"L Corral","year":"2007","unstructured":"Corral L, Ventura J, Herrero J, Monfort J, Juncadella M, Gabarros A, et al. Improvement in GOS and GOSE scores 6 and 12 months after severe traumatic brain injury. Brain injury\u202f: [BI]. 2007;21:1225\u201331.","journal-title":"Brain injury : [BI]."},{"issue":"9","key":"4923_CR33","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S1474-4422(18)30231-X","volume":"17","author":"JJ Bazarian","year":"2018","unstructured":"Bazarian JJ, Biberthaler P, Welch RD, Lewis LM, Barzo P, Bogner-Flatz V, et al. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. Lancet Neurol. 2018;17(9):782\u20139.","journal-title":"Lancet Neurol."},{"issue":"9","key":"4923_CR34","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1474-4422(22)00256-3","volume":"21","author":"FK Korley","year":"2022","unstructured":"Korley FK, Jain S, Sun X, Puccio AM, Yue JK, Gardner RC, et al. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study. The Lancet Neurology. 2022;21(9):803\u201313.","journal-title":"The Lancet Neurology."},{"issue":"2","key":"4923_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1124\/jpet.121.001023","volume":"382","author":"MI Hiskens","year":"2022","unstructured":"Hiskens MI. Targets of neuroprotection and review of pharmacological interventions in traumatic brain injury. The Journal of Pharmacology and Experimental Therapeutics. 2022;382(2):149\u201366.","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"4923_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-108337","volume":"16","author":"M Bouras","year":"2026","unstructured":"Bouras M, Costerousse O, Verret M, O\u2019Connor S, Zarychanski R, Gagnon MA, et al. Excitatory amino acid inhibitors in adults with acute moderate to severe traumatic brain injury: a systematic review and meta-analysis. BMJ Open. 2026;16(3):e108337.","journal-title":"BMJ Open."},{"issue":"26","key":"4923_CR37","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1411090","volume":"371","author":"BE Skolnick","year":"2014","unstructured":"Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371(26):2467\u201376.","journal-title":"N Engl J Med."},{"key":"4923_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00354","volume":"8","author":"T Zoerle","year":"2017","unstructured":"Zoerle T, Carbonara M, Zanier ER, Ortolano F, Bertani G, Magnoni S, et al. Rethinking neuroprotection in severe traumatic brain injury: toward bedside neuroprotection. Front Neurol. 2017;8:354.","journal-title":"Front Neurol"},{"issue":"9","key":"4923_CR39","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, G\u00e9linas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation\/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46(9):e825\u201373.","journal-title":"Crit Care Med."},{"issue":"11","key":"4923_CR40","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.3174\/ajnr.A3395","volume":"34","author":"MB Hulkower","year":"2013","unstructured":"Hulkower MB, Poliak DB, Rosenbaum SB, Zimmerman ME, Lipton ML. A decade of DTI in traumatic brain injury: 10 years and 100 articles later. AJNR Am J Neuroradiol. 2013;34(11):2064\u201374.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"14","key":"4923_CR41","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1056\/NEJMoa1301372","volume":"369","author":"PP Pandharipande","year":"2013","unstructured":"Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369(14):1306\u201316.","journal-title":"N Engl J Med."},{"key":"4923_CR42","doi-asserted-by":"crossref","unstructured":"Vespa P, Boonyaputthikul R, McArthur D, Miller C, Etchepare M, Bergsneider M, et al. Vespa P, Boonyaputthikul R, McArthur DL, Miller C, Etchepare M, Bergsneider M, Glenn T, Martin N, Hovda DAIntensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate\/pyruvate ratio after traumatic brain injury. Neurol Crit Care 34:850-856. Critical care medicine. 2006;34:850-6.","DOI":"10.1097\/01.CCM.0000201875.12245.6F"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04923-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04923-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04923-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:49:25Z","timestamp":1781048965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04923-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4923"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04923-4","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. The study was approved by the Research Ethics Committee of Mazandaran University of Medical Sciences (Approval No. IR.MAZUMS.IMAMHOSPITAL.REC.1403.173). Written informed consent was obtained from LARs of all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"379"}}